Clinical trial
A Randomized, Placebo-Controlled, Double-Blind, Single-Center Clinical Trial to Evaluate the Efficacy of Normast3 in Adult Patients With Diabetic Polyneuropathy
NCT07689214 is registered in ClinicalTrials.gov with University of Roma La Sapienza as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Placebo-Controlled, Double-Blind, Single-Center Clinical Trial to Evaluate the Efficacy of Normast3 in Adult Patients With Diabetic Polyneuropathy
- Lead sponsor
- University of Roma La Sapienza
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- July 17, 2024
- Completion date
- September 30, 2026
- Enrollment
- 40 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
diabete type 2